Here's the presentation David Einhorn just gave to a room of elite hedge fund managers
Advertisement
Thomson Reuters
Advertisement
In it, he explained his long thesis for pharmaceutical giant, Bayer.
Last year Bayer spun off its chemicals company, Covestro, and then in September announced a deal to take over seed-maker Monsanto.
That deal is pending approval from a dizzying number of regulators around the world.
Now, here's the crux of why Einhorn likes Bayer in all of this:
Advertisement
"Whether they make it to the altar, or get thwarted along the way, there's going to be a celebration for Bayer shareholders either way. With cake. And we like cake," he said.
Scroll down to get his full take on why.
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
- Vodafone Idea FPO allotment – How to check allotment, GMP and more
- Satellite monitoring shows large expansion in 27% identified glacial lakes in Himalayas: ISRO
- Vodafone Idea shares jump nearly 8%
- Indians can now get multiple entry Schengen visa with longer validity as EU eases norms
- Investing Guide: Building an aggressive portfolio with Special Situation Funds
- Markets climb in early trade on firm global trends; extend winning momentum to 3rd day running